CClinicalTrials.gg
CompletedNCT06437756Updated Jul 3, 2024

Effects of Theraband Resistance Training on Muscle Strength in Coronary Artery Diseases

An interventional study of Theraband resistance training and Conventional Resistance Training in Coronary Artery Disease, sponsored by Riphah International University. Completed at 1 site in Pakistan. Per ClinicalTrials.gov, last updated 2024-07-03.

Sponsored by Riphah International University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Sex
All
01

Study summary

To compare the effects of Theraband Resistance Training with Conventional Resistance Training on muscle strength in coronary artery diseases

02

Conditions studied

03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 38 is below the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants having a documented diagnosis of CAD, confirmed by a medical professional.
  • Individuals with a history of myocardial infarction (heart attack), angina, or evidence of significant coronary artery stenosis.
  • Stable CAD who were not experiencing acute coronary events, such as recent heart attacks or unstable angina.
  • Patients who were able to perform exercises with TheraBand.
  • Reduced muscle strength of upper limb/lower limb

Exclusion criteria

Exclusion Criteria:

  • Patients over the age of 75 years.
  • Exclude individuals with a recent history of Theraband resistance training.
  • Severe cardiovascular complications such as heart failure with reduced ejection fraction, severe arrhythmias, or uncontrolled hypertension.
  • Patients with unstable conditions or cardiac episodes.
  • Individuals who had undergone major cardiovascular surgery (e.g., coronary artery bypass grafting) within the last six months.
  • Ejection fraction \< 40%
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Theraband resistance training

    Other: Theraband resistance training

  • Active comparator
    Conventional Resistance Training

    Other: Conventional Resistance Training

Interventions

  • OtherTheraband resistance training

    Three sessions of 30 minutes each was used to complete the intervention over the course of six weeks (two sets of 12 repetitions). The participants were warmed up by stretching for 10 minutes before each session Participants were advised to take 5 mins rest before moving to next movement if they would feel fatigued after one movement. Thera-Band was utilized in only three different colors for the workouts.

  • OtherConventional Resistance Training

    The intervention was carried out over the course of six weeks in three sessions of 30 minutes each (two sets of 12 repetitions). The participants were warmed up by stretching for 10 minutes before each session. The resistance-training program was performed with Universal weights.

06

What researchers measure

Primary outcomes

  1. Hand Held Dynamometer

    If testing techniques are consistent, handheld dynamometry is a valid approach to assess the strength state and change in strength status. Hand-held dynamometry can be a reliable assessment technique when practiced by a single experienced tester

    Time frame: 6 week

  2. Modified BORG Scale

    The Modified Borg Dyspnea Scale is numerical rating scale ranging from 0 to 10 and is used to measure dyspnea that patient report during sub-maximal exercise and is regularly administered during six-minute walk test. Changes from the baseline will be measured

    Time frame: 6 week

  3. Chadler Fatigue Scale

    It is a self-administered questionnaire for assessing the degree and severity of fatigue/tiredness in epidemiological populations, both clinical and non-clinical. The Chadler Fatigue Scale (CFS) was originally perceived as comprising two subscales that evaluate fatigue in the physical and mental domains. Items are rated on a 4-point Likert scale (0 = better than usual, 1 = no more than usual, 2 = worse than usual, 3 = much worse than usual), with higher scores indicating greater fatigue. Changes from the baseline are measured

    Time frame: 6 week

  4. 6 Min walk test (Distance in meters)

    Changes from the baseline, Body Mass Index can be define as statistical index utilizing an individuals height and weight to give an estimation of muscle versus fat in female and male of all ages. It is determined by taking an individual weight in kilograms, separated by their height in meters squared, or BMI = weight (in kg)/height (in m square).

    Time frame: 6 week

  5. The 30 Second Sit to Stand Test(30SSST) for lower limb strength

    The 30-Second Sit to Stand Test evaluates older people's leg strength and endurance using a foldable chair without arms. Participants stand with feet positioned back from knees, arms crossed, and arms crossed. The examiner counts stand within 30 seconds, determining the score.

    Time frame: 6 week

07

Study locations

1 site
  • Al Nafees Medical Hospital
    Islamabad, Federal 44000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06437756
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
May 31, 2024
Start date
May 1, 2024
Primary completion
Jul 1, 2024
Completion
Jul 1, 2024
Last update
Jul 3, 2024

Study contacts

Muhammad Iqbal Tariq, PhD*
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion